AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Hrstka, Roman, Brychtova, Veronika, Fabian, Pavel, Vojtesek, Borivoj, Svoboda, Marek
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2013
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776368/
https://ncbi.nlm.nih.gov/pubmed/24167368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/761537
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares